858 Therapeutics

Developer of small-molecule therapeutics for the treatment of cancer

placeSan Diego, California, United States calendar_todayFounded 2019 groups25 employees language 8five8tx.com

Innovation

6 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 112 times.

YearFilings
20233
20243
20255
20261

Social engagement

Social engagement: 2.5K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Avidity Partners, Versant Ventures.

Investor typeCountShare
Venture capital343%
Private equity114%
Bank & private debt229%
Other / undisclosed114%

Recent activity

21 May 2026
Event
ASCO Annual Meeting
Coming soon